Boston Scientific Corp (BSX)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account
Sell

$105.00

Buy

$106.20

arrow-up$1.18 (+1.13%)

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Prices updated at 17 May 2025, 00:52 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Income statement

20172018201920202021202220232024
9,048m9,823m10,735m9,913m11,888m12,682m14,240m16,747m
6,387m6,940m7,554m6,403m8,177m8,727m9,896m11,490m
1,531m1,659m1,740m684m1,824m2,034m2,418m3,002m
16.9216.8916.216.9015.3416.0416.9817.93
104m1,671m4,700m-82m1,041m698m1,593m1,854m
2,006m2,557m2,171m1,405m2,510m2,747m3,446m3,856m
Sales, General and administrative3,294m3,569m3,941m3,787m4,359m4,520m5,190m5,984m
Interest expenses229m241m473m361m341m470m265m305m
Provision for income taxes828m-249m-4,013m2m36m443m393m436m
Operating expenses4,856m5,281m5,814m5,719m6,353m6,693m7,478m8,488m
Income before taxes933m1,422m687m-79m1,076m1,141m1,985m2,282m
Net income available to common shareholders104m1,671m4,700m-115m985m642m1,570m1,853m
0.081.213.38-0.080.690.451.081.26
Net interest income-224m-238m-443m-358m-337m-460m-243m-198m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.081.193.33-0.080.690.451.071.25
Free cash flow per share0.34610.35460.44080.69491.08330.38591.12651.2762
Book value/share5.52465.98666.952410.986711.547412.307612.884514.0435
Debt equity ratio0.5387250.5504870.6385390.6215180.5528480.5270290.4647580.430363

Balance sheet

20172018201920202021202220232024
Current assets3,822m4,003m4,699m6,694m6,317m5,760m6,514m6,920m
Current liabilities5,654m5,260m4,866m3,681m4,274m3,803m4,933m6,399m
Total capital10,826m13,496m22,469m24,445m25,418m26,484m27,847m30,612m
Total debt5,616m7,030m10,284m9,539m9,451m9,282m9,492m11,147m
Total equity7,011m8,725m13,877m15,327m16,623m17,574m19,281m21,770m
Total non current liabilities--------
Loans3,815m4,771m8,592m9,118m8,795m8,910m8,566m8,842m
Total assets19,042m20,999m30,565m30,777m32,229m32,469m35,136m39,395m
Total liabilities--------
Cash and cash equivalents188m146m217m1,734m1,925m928m865m414m
Common stock1,373m1,385m1,395m1,417m1,426m1,433m1,466m1,475m

Cash flow

20172018201920202021202220232024
Cash at beginning of period487m1,017m829m607m1,995m2,168m1,126m1,055m
Cash dividends paid----28m-55m-55m-28m-
976m-178m1,226m986m1,316m938m1,703m2,365m
Investments (gains) losses-1,010m-1,921m-5,041m-411m-1,597m-2,011m-2,574m-5,687m
1,017m829m607m1,995m2,168m1,126m1,055m606m
Net income--------
1,426m310m1,836m1,508m1,870m1,526m2,503m3,435m
-450m-488m-610m-522m-554m-588m-800m-1,070m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.